CIK 0001787297 · Non-accelerated filer<br>Smaller reporting company
Passage BIO, Inc.
Sign in to watch- Ticker
- PASG
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 822729751
- Phone
- 2678660312
- Business address
- ONE COMMERCE SQUARE, 2005 MARKET STREET, 39TH FLOOR, PHILADELPHIA, PA, 19103
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 65 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-15 | Fotopoulos Alexandros Chief Technical Officer | Option exercise | +12,500 | 32,745 | ||
| 2023-06-15 | Fotopoulos Alexandros Chief Technical Officer | Option exercise · Restricted Stock Units | −12,500 | 25,000 | ||
| 2023-05-25 | Woiwode Thomas Director | Grant or award · Director Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2023-05-25 | Porter Derrell Director | Grant or award · Director Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2023-05-25 | Kapadia Sandip Director | Grant or award · Director Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2023-05-25 | Kamarck Michael E. Director | Grant or award · Director Stock Option (Right to Buy) | +21,567 | 21,567 | ||
| 2023-05-25 | Islam Saqib Director | Grant or award · Director Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2023-05-25 | GOWEN MAXINE Director | Grant or award · Director Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2023-05-25 | Countouriotis Athena Director | Grant or award · Director Stock Option (Right to Buy) | +24,000 | 24,000 | ||
| 2023-04-18 | King Simona Chief Financial Officer | Option exercise | +6,250 | 6,250 | ||
| 2023-04-18 | King Simona Chief Financial Officer | Sale | −2,053 | $1.05 | $2K | 2,053 |
| 2023-04-18 | King Simona Chief Financial Officer | Option exercise · Restricted Stock Units | −6,250 | 18,750 | ||
| 2023-03-15 | Chou William President and CEO | Grant or award · Employee Stock Option (right to buy) | +608,615 | 608,615 | ||
| 2023-03-15 | King Simona Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +140,000 | 140,000 | ||
| 2023-03-15 | Forman Mark S Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2023-03-15 | Cale Edgar B. GC & Corporate Secretary | Grant or award · Employee Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2023-03-15 | Fotopoulos Alexandros Chief Technical Officer | Grant or award · Employee Stock Option (right to buy) | +175,000 | 175,000 | ||
| 2022-12-01 | Kapadia Sandip Director | Sale | −5,000 | $1.19 | $6K | 0 |
| 2022-11-22 | Fotopoulos Alexandros Chief Technical Officer | Option exercise | +12,500 | 23,965 | ||
| 2022-11-22 | Fotopoulos Alexandros Chief Technical Officer | Sale | −3,720 | $1.33 | $5K | 20,245 |
Page 6 of 8 · 152 trades